Just in:
OpenAI limits Sol launch amid cyber risks // Tehran blocks French role in Hormuz clearance // Afogreen Build Highlights Growing Adoption of Building Performance Modelling in Australia’s Sustainability-Driven Construction Sector // Payments giants back shared Open USD stablecoin // 5 Law Firms Making a Difference in Cincinnati // Where Minds Meet to Launch Space Economy Association Off the Ground // Cheap RAT spreads through Telegram channels // This summer will never stop us from our wellness routine // China’s digital hub Hangzhou hosts conference on AI, OPC // Why your AI transformation can fail — and it’s not the technology // CG Capital, the Leader in Branded Residences in Thailand, Marks Milestone Success for InterContinental Residences Bangkok Asoke Amid Global Economic Uncertainty // Bid To Rebuild Bengal To Its Old Glory Is Welcome, Though Difficult // DSQ Real Estate Highlights Post-Purchase Advisory as a Growing Need for Overseas Dubai Property Owners // World’s First Commercial Multimodal LLM for Cultural Tourism Enters Broad Application // PRHK 2026 Benchmark Report highlights how Hong Kong’s IPO revival, AI, and the GBA are reshaping the SAR’s PR industry // ClawHub breach exposes agent marketplace risk // Masdar starts Kazakh wind power push // Hawaii tests plastic waste in roads // Bangladesh-China Joint Statement On Teesta Cooperation Poses A Big Challenge To India // Save the Children Hong Kong’s Play to Thrive: Prioritising Personal Growth Over Competitive Success //

Key findings of investigation into harder-to-abuse opioids

The Associated Press and the Center for Public Integrity investigated how pharmaceutical companies are using their political clout to push a new form of opioids as their answer to the epidemic of prescription painkiller abuse. The pills are marketed as abuse-deterrents because they usually are difficult to crush and dissolve, but they also are lucrative for the industry. Some key findings:

  • Lawmakers in 35 states introduced more than 100 bills over the last two years dealing with the harder-to-abuse opioids. Roughly half included nearly identical language requiring insurers to cover the new formulations, and several of the sponsors said they received the wording from pharmaceutical lobbyists.

  • At least 21 bills related to abuse-deterrent drugs have become state law in the last five years, including five that require insurers to pay for the more expensive drugs.

  • Manufacturers of abuse-deterrent opioids have spent more than $20 million on federal lobbying efforts that included legislation promoting those drugs between 2012 and 2015.

  • Drugmakers also have tried to influence state attorneys general. Two of the biggest, Purdue Pharma and Pfizer, gave a total of $950,000 to the Republican and Democratic attorneys general associations in 2015 and 2016, more than in the previous four years combined.

  • Abuse-deterrent painkillers represented less than 5 percent of all opioids prescribed last year but generated more than $2.4 billion in sales _ roughly a quarter of the entire U.S. market for the drugs.

  • Converting the U.S. Department of Veterans Affairs medical system exclusively to the new formulations, according to one recent VA estimate, would increase its spending on prescription painkillers more than tenfold, to over $1.6 billion annually.

  • A federal bill passed this summer that includes a provision promoting abuse-deterrent opioids is expected to cost the federal government $75 million in lost Medicaid payments over 10 years. Makers of such harder-to-abuse drugs spent more than $1.7 million on lobbying efforts in 2016 that included that bill.

This story was co-published with The Associated Press.

ADVERTISEMENT



Source link



Notice an issue?

Arabian Post strives to deliver the most accurate and reliable information to its readers. If you believe you have identified an error or inconsistency in this article, please don't hesitate to contact our editorial team at editor[at]thearabianpost[dot]com. We are committed to promptly addressing any concerns and ensuring the highest level of journalistic integrity.


ADVERTISEMENT
Social Media Auto Publish Powered By : XYZScripts.com